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Lung membranes from fetuses of diabetic animals bound sipnificaGly more insulin than did those of control fetuses. ~catcharvd analysis yielded curvilinear plots of bound fractions versus total amount of insulin bound suggesting the presence of more than one class of receptors or negative cooperativity. Assuming two classes of receptors, one of high affiity and low capacity and another of low affinity and high capacity, we found that fetal membranes had a five-fold increase in binding capacity of high-affinity receptors as compared to adult membranes. In spite of marked hyperinsulinemia in the offspring of the diabetic animal, the fetal lung, far from experiencing a down-regulation of insulin receptor binding, showed increased insulin binding. This findiig is consistent with observations made previously on circulating monocytes of infants of diabetic mothers.
Speculation
Hyperinsulinemia occurring postnatally appears to lead to down-regulation of insulin binding. Although the mechanisms of down-regulation are not clearly understood, from a teleological standpoint the phenomenon may be viewed as partially protecting the organism from the effects of hyperinsdinism because less binding sites are available for insulin to exert its effects on target tissues. In the fetus, this protective mechanism does not appear to exist in at least two tissues examined thus far, circulating monocytes of the human and lung tissue of the rabbit. The fetus with hyperinsulinemia may therefore be subject to the double jeopardy of higher concentrations of insulin and higher binding of insulin to its target tissues.
Neonatal respiratory distress syndrome (RDS) has been recognized as a major factor in the morbidity and high mortality rates 10 not well defmed (9). Certain factors sich as degree of prematurity and the route of delivery contribute to the greater than normal incidence of RDS in these infants. When such factors are controlled for in the analyses of available data, however, the incidence of RDS remains 5-to 6-fold greater than IDM than in the normal population (27) unless maternal diabetes is rigidly controlled during inpatient supervision of the mother in the latter part of her pregnancy (14).
Insufficient quantities of surface-active phospholipids in the neonatal lung are associated with development of RDS (4). Studies by others and ourselves have shown that insulin in concentrations comparable to those observed in IDM at birth can significantly impair the synthesis of surface active phospholipids by fetal lung tissue in vitro (12, 21, 30). Recognition of the specific effects of insulin on this critical aspect of fetal lung metabolism prompted us to characterize properties of insulin receptors in fetal lung tissue. Furthermore, inasmuch as maternal diabetes is known to affect the properties of insulin receptors in other tissues (19), it was necessary to investigate the effects of maternal diabetes on fetal lung receptors.
MATERIALS AND METHODS
Twelve pregnant New Zealand albino rabbits, conception timed to within 3 hr, were studied in pairs in six separate experiments. Six animals received alloxan (60 mg/kg body weight) in sterile 0.9% NaCl solution intravenously on day 14 of pregnancy, at a time when this injection is known to cause minimal disturbance of fetal pancreatic endocrine function (2). For 24 hr after the injection, these animals received 10% dextrose in water for drinking. The remaining animals, which served as controls, received intravenous saline without alloxan. On day 28 of gestation, the fetuses were delivered by caesarean section after sacrificing the doe with intravenous pentobarbital followed by KC1, as described previously (21). Both fetal and adult lungs were excised, placed in ice-cold saline, blotted and extraneous bronchial tissue dissected away.
For each experiment, plasma membranes from pooled fetal lungs and adult lung were prepared by modification of the method described by Morishige et al. (18) . Lung tissue was minced with scissors, placed in 0.3 M sucrose, homogenized on ice using a Polytron homogenizer, and filtered through 2 to 3 layers of cotton gauze. The filtered homogenate was centrifuged at 3000 x g for 10 min. The supernatant fraction was recovered and centrifuged at 16,000 Xg for 20 min. The resultant membrane pellet was washed twice in 50 mM Tris buffer (pH 7.6) and resuspended at a final concentration of 1 g original wet weight to 2 ml Tris buffer. All steps were carried out at 0 to 4OC. Insulin binding studies were performed immediately after membrane preparation because significant diminution in binding was observed to occur within 2 to 7 days (18). Maternal and pooled fetal blood were saved for subsequent determination of glucose and insulin concentrations.
Mono-i~do-'~~I-insulin with a specific activity of 80 to 150 pCi/ was prepared by the method of Freychet et al. (8) . Binding of '$1 insulin to plasma membranes was determined in duplicate after 3 hr incubation at 4OC. Resuspended membranes were incubated with 50 p1 of 125~-insulin in 50 mM Tris buffer (pH 7.4) containing 1% bovine serum albumin and unlabeled insulin in concentrations ranging from 0.2 ng/ml to 100 pg/ml in a final volume of 0.5 ml. Final membrane protein concentrations ranged from 0.5 to 1.5 mg/ml. Bound insulin was separated from unbound insulin by vacuum suction in a manifold filtration apparatus (Millipore Corporation), with cellulose acetate filters of pore size 0.45 p. Each filter was washed with 10 ml ice-cold buffer, and radioactivity remaining on the filter was determined in a well counter.
Comparison of degradation rates of '251-insulin by lung membrane preparations was made by incubating 100 p1 of '251-insulin, approximately 0.2 ng, as used in the binding assay in 100 p1 glycine-NaOH buffer (ph 8.6) and 1% bovine serum albumin, with 100 p1 of membrane suspension in duplicate at 37°C for up to 30 min. Duplicate 20 p1 aliquots of this incubation mixture were taken at 0, 5, 10, and 30 min, added to 0.5 ml Tris buffer and 0.5 ml 10% trichloroacetic acid on ice. The trichloroacetic acid precipitate was recovered, and percent degradation was calculated from the decrease in precipitable counts corrected for the decrease in counts observed in control tubes incubated without lung tissue.
Specific binding of 1251-insulin to lung plasma membranes under equilibrium conditions was calculated from the differences between insulin bound in the presence and absence of unlabeled insulin (100 pg/ml). Nonspecific binding, expressed as the percentage of total radioactive counts added, was 1.4% + 0.4% for fetal tissues and 1.9 + 0.5 for maternal tissues. Under the conditions of assay, specific binding of tracer insulin was shown to increase linearly with increasing lung membrane protein concentrations (Fig. 1) . All data were normalized to a final membrane protein concentration of 1 mg/ml. Data from competitive insulin binding studies was subjected to Scatchard analysis (28). Binding capacities and equilibrium constants determined from such analyses using a model of two receptor classes (7) followed the procedure of regression analysis as outlined by Blanchard et al. (5).
Activity of 5'-nucleotidase in homogenates and crude membranes was determined by the method of Aronson and Touster (3). Inorganic phosphate was assayed by a colorimetric procedure described by Ames (1). Protein was determined by the procedure of Lowry et al. (17) . All assays were performed within 2 wk of membrane preparation. Plasma glucose was determined by reduction of ferricyanide on an Antoanalyzer. Insulin was measured by radioimmunoassay according to the method of Soeldner and Slone (3 1). All data are presented as the mean + 1 S.D. unless otherwise specified. Statistical comparisons were performed for all data utilizing the two-tailed Student t test with significance determined at a level of 5% or less. For comparison of insulin binding to membrane pools, analysis of variance of the regression lines obtained for the binding curves was used.
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RESULTS
Characteristics of maternal and fetal animals from control and alloxan-treated groups are shown in Table 1 . Maternal glucose values were significantly greater in the alloxan-treated diabetic groups than in control (246 + 81 versus 98 + 7.0; P < 0.001).
Maternal insulin was undetectable in the alloxan-treated group. The lower limit of insulin detectable by the radioimmunoassay method was 4 pU/ml. Fetal birth weights were lower in the diabetic offspring than the controls. Fetal glucose levels measured in the pooled serum were significantly greater in the offspring of the alloxan-treated mothers than in the control offspring (160 + 69 versus 55 + 12 mg/dl; P < 0.02), reflecting a placental gradient of 1.2 for the diabetic animals and 1.6 for the normal animals. The mean insulin level of the diabetic offspring was more than double that of the control fetuses.
Crude membranes prepared from fetal and maternal lung tissue showed approximately two-fold enrichment of 5'-nucleotidase, a plasma membrane marker enzyme ( Table 2) . Binding of 1251-insulin to membranes prepared from fetal and adult lung tissues was studied, and competitive binding curves from these studies are shown in Figure 2 . Lung membranes from fetuses of alloxantreated diabetic mothers bound significantly more insulin than did lung membranes from control fetuses at tracer concentrations. Over the entire range of insulin concentrations at which insulin binding was studied, binding of insulin by fetal diabetic membranes was significantly higher than in normal controls (P < 0.001). Although mean values of insulin binding by membranes from maternal controls were somewhat higher, they were not significantly different from binding by membranes from alloxan-
Scatchard analyses of these competitive binding data are shown in Figure 3 . Eachpoint represents the mean value obtained at that insulin concentration for all experiments. The Scatchard plots are curvilinear for both maternal and fetal membranes. Figure 3A depicts binding of insulin to membranes of the fetal animal groups, and Figure 3B depicts binding to lung membranes from maternal control and alloxan-diabetic rabbits.
Analysis of these curvilinear Scatchard plots using a 2 receptor class model was carried out. The slope determined by linear regression analysis of the curve representing insulin bound at lower concentrations (0.2 to 10 ng/ml) gives an estimate of the equilibrium affinity constant of a class of receptors of high affinity, and the intercept of the line of regression with the x-axis gives an estimate of the binding capacity. Similar calculations were made to define the characteristics of the low-affinity receptors using data from insulin bound in the presence of insulin (10 to 100 ng/ ml). The data derived from these calculations are shown in Table  3 . High-and low affinity constants from maternal control lung membranes differ by one order of magnitude, and are comparable to those reported by Morishige et al. (18) for control adult rat lung. Maternal diabetic lung membranes have binding capacities of both high-and low-affinity receptors comparable with controls.
Lower absolute values of affinity constants in both classes of receptors are observed in these diabetic preparations when compared to controls. Fetal control membranes have four-to five-fold greater numbers of affinity receptor as compared to maternal controls; in addition, they have five-to ten-fold more low-affinity receptors than maternal tissues. ,
Rates of '251-insulin degradation by crude membrane preparations were compared for all four groups studied, and the data from these studies are shown in Figure 4 . It is apparent that fetal membrane preparations from both control and diabetic offspring degrade significantly more 1251-insulin per 100 pg membrane (Fig. 1) . Scatchard analysis of insulin binding to maternal lung plasma membranes. 5.1 x lo-'' 1.4 X lo9 2.2 X lo-" control Maternal 6.7 X lo9 4.7 X lo-" 7.2 X 10' 2.2 X lo-'' diabetic Fetal con-1.5 x lo9 1.5 x lo-'' 1.0 x 10' 1.2 x trol Fetal dia-2.3 x lo9 2.2 x lo-'' 1.5 X lo8 2.1 X lo-' betic ' Class 1 (high-affinity receptors) are calculated by linear regression utilizing binding data obtained at points from 0.2 to 10 ng insulin. The low-affinity, high-capacity receptors (class 2) are calculated from binding data obtained between points 10 to 100 ng using the method of Blanchard et al. (5).
protein than do similarly prepared maternal membranes. Although fetal diabetic offspring have somewhat greater rates of insulin degradation than do control fetal membranes at 5-and 10-min samples, the difference is not significant. At 30 min, they are indistinguishable from one another. Insulin degradation rates by lung membranes from both control and diabetic mothers are similar.
DISCUSSION
Maternal treatment of rabbits or rats with a diabetogenic agent as a model for diabetes during pregnancy has been used by several groups in studies of fetal lung metabolism (6, 26, 32). The rabbit model used by us resembles the human diabetic pregnancy in that maternal glucose concentrations are higher and insulin concentrations lower in the diabetic than in controls. Furthermore, in the offspring of the diabetic mother both glucose and insulin concen-
